Rebalix
Logo SPDRSPDR · sheet of 10 September 2026
ETF sheet · official issuer and register data

State Street® SPDR® MSCI Europe Small Cap Value Weighted UCITS ETF

ZPRX · IE00BSPLC298 · EUR · domicile Ireland
Equity · Europe · Small cap · ValueSFDR art. 6 (inferred)
Index tracked: MSCI Europe Small Cap Value Weighted Index
TER
0.30%+ trans. 0.05%
Fund size
793 m EUR
Tracking difference
+0.30%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (optimised)
Income
Accumulating
Launch 17 Feb 2015 · costs from the KID as of 2 Sept 2026 · 804 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
Investment objective The investment objective of the Fund is to track the performance of European small capitalisation equities with a higher weighting applied to equities exhibiting low valuation characteristics. The Fund seeks to track the performance of the MSCI Europe Small Cap Value Weighted Index (the "Index") as closely as possible. The Fund is an index tracking fund (also known as a passively managed fund). Investment policies The Fund invests primarily in securities included in the Index. These securities include smaller sized European companies…

Performance since series start (in euro) — base 100

18 Feb 20158 Sept 2026 · dividends reinvested where declared by the issuer
20162018202020222024202623473232
High 234 (27 Aug 2026) · low 73 (19 Mar 2020) · last 232. Past performance is not indicative of future results.

Returns in euro

1 year+21.9%
3 years+63.2%
5 years+50.6%
10 years+129.5%
Since series start+132.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.12%14.39%16.27%
Max drawdown−11.23%−16.09%−27.75%
Sharpe1.320.960.44
Sortino1.991.360.61
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ZPRX · IE00BSPLC2981
RebalixZPRX · IE00BSPLC298 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+25.31%+24.83%+0.48%
2024+5.19%+4.80%+0.38%
2023+16.21%+16.18%+0.03%
2022−14.27%−14.61%+0.34%
2021+28.30%+28.91%−0.61%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 804 securities · top-10 weight = 9.1%
Top holdingsWeight
WPP Plc1.2%
thyssenkrupp AG1.2%
Adecco Group AG1.2%
Valeo SE0.9%
Randstad NV0.8%
DCC Energy Plc0.8%
TUI AG0.8%
Barratt Redrow plc0.8%
SCOR SE0.7%
Air France-KLM SA0.7%
Countries (% of fund)
United Kingdom31.4%France11.4%Germany11.0%Sweden8.4%Switzerland7.3%
Sectors (% of fund)
Industrials26.1%Consumer Discretionary15.0%Financials15.0%Materials11.3%Real Estate7.5%

Listing venues

ESMA register (FIRDS) and official exchange lists
ZPRX · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 18 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ssga.com/library-content/kids?isin=IE00BSPLC298&documentType=kid&c
Factsheet · www.ssga.com/library-content/products/factsheets/etfs/emea/factsheet-e
Prospectus · www.ssga.com/library-content/products/fund-docs/etfs/emea/1-IE-EN-FP-I
The live sheet, always up to date
rebalix.com/en/etf/IE00BSPLC298
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ZPRX · IE00BSPLC2982